Neuronetics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Neuronetics Stock Summary

Neuronetics competes with Burning Rock, DarioHealth Corp, Sera Prognostics, Biodesix, and Fonar. Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. Neuronetics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 198 people.

Neuronetics Key Financial Ratios

Neuronetics Key Balance Sheet Accounts

Neuronetics Key Income Statement Accounts

Neuronetics Key Cash Accounts

Neuronetics Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Neuronetics's current stock value. Our valuation model uses many indicators to compare Neuronetics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Neuronetics competition to find correlations between indicators driving Neuronetics's intrinsic value. More Info.Neuronetics is rated below average in return on equity category among its peers. It is rated fifth in return on asset category among its peers . At this time, Neuronetics' Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Neuronetics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Neuronetics Systematic Risk

Today, most investors in Neuronetics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Neuronetics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Neuronetics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Neuronetics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Neuronetics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Neuronetics based on widely used predictive technical indicators. In general, we focus on analyzing Neuronetics Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Neuronetics's daily price indicators and compare them against related drivers.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.